| Literature DB >> 24699641 |
Mauro Rinaldelli1, Enrico Ravera1, Vito Calderone1, Giacomo Parigi1, Garib N Murshudov2, Claudio Luchinat1.
Abstract
The program REFMAC5 from CCP4 was modified to allow the simultaneous use of X-ray crystallographic data and paramagnetic NMR data (pseudocontact shifts and self-orientation residual dipolar couplings) and/or diamagnetic residual dipolar couplings. Incorporation of these long-range NMR restraints in REFMAC5 can reveal differences between solid-state and solution conformations of molecules or, in their absence, can be used together with X-ray crystallographic data for structural refinement. Since NMR and X-ray data are complementary, when a single structure is consistent with both sets of data and still maintains reasonably `ideal' geometries, the reliability of the derived atomic model is expected to increase. The program was tested on five different proteins: the catalytic domain of matrix metalloproteinase 1, GB3, ubiquitin, free calmodulin and calmodulin complexed with a peptide. In some cases the joint refinement produced a single model consistent with both sets of observations, while in other cases it indicated, outside the experimental uncertainty, the presence of different protein conformations in solution and in the solid state.Entities:
Keywords: PCS; RDC; REFMAC; X-ray; structure refinement
Mesh:
Substances:
Year: 2014 PMID: 24699641 PMCID: PMC4306559 DOI: 10.1107/S1399004713034160
Source DB: PubMed Journal: Acta Crystallogr D Biol Crystallogr ISSN: 0907-4449
Structural parameters and quality of the refined structure for the analyzed proteins
For cMMP1, three different structures are present in the crystal asymmetric unit. In this case, the values are averaged over all the structures.
| cMMP1 | Ub | GB3 | CaM | CaMDAPk peptide | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| X-ray ( | + PCS + RDC | X-ray ( | + RDC | X-ray ( | + RDC | X-ray ( | + RDC | X-ray ( | + PCS + RDC | |
| Resolution () | 2.20 | 1.26 | 1.10 | 1.00 | 1.70 | |||||
|
| 0.214 | 0.220 | 0.128 | 0.131 | 0.112 | 0.111 | 0.126 | 0.130 | 0.255 | 0.260 |
|
| 0.264 | 0.267 | 0.158 | 0.160 | 0.132 | 0.134 | 0.142 | 0.147 | 0.304 | 0.307 |
|
| 0.414 | 0.160 | 0.360 | 0.121 | 0.146 | 0.081 | 0.398 | 0.308 | 0.540 | 0.201 |
|
| 0.136 | 0.055 | 0.150 | 0.079 | ||||||
| No. of violating RDC, PCS data | 133/393, 61/516 | 30/393, 4/516 | 678/1971 | 98/1971 | 170/877 | 63/877 | 94/314 | 89/314 | 102/214, 59/323 | 37/214, 23/323 |
| Backbone r.m.s.d. () | 0.039 | 0.060 | 0.022 | 0.028 | 0.121 | |||||
The tolerance for RDCs and PCSs was set to 2Hz and 0.1p.p.m., respectively.
Structural parameters, quality of the refined structures for the analyzed proteins and weights used in the minimization procedures
| cMMP1 | Ub | GB3 | CaM | CaMDAPk peptide | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| X-ray ( | + PCS + RDC | X-ray ( | + RDC | X-ray ( | + RDC | X-ray ( | + RDC | X-ray ( | + PCS + RDC | |
| R.m.s.d. bond length () | 0.015 | 0.017 | 0.020 | 0.020 | 0.021 | 0.022 | 0.021 | 0.025 | 0.018 | 0.023 |
| R.m.s.d. bond angle () | 1.751 | 2.385 | 1.917 | 2.094 | 1.933 | 2.056 | 1.743 | 2.080 | 1.828 | 2.671 |
| R.m.s.d. chiral volume (3) | 0.129 | 0.112 | 0.128 | 0.116 | 0.227 | 0.098 | 0.091 | 0.113 | 0.112 | 0.155 |
| Pep2 deviation () | 2.076 | 2.333 | 0.361 | 0.377 | 0.239 | 0.245 | 1.142 | 1.700 | 0.462 | 0.459 |
| Ramachandran (%) | ||||||||||
| Core | 89.8 | 91.6 | 91.9 | 91.9 | 98.1 | 98.1 | 94.7 | 94.7 | 91.6 | 90.1 |
| Allowed | 9.9 | 7.9 | 7.3 | 7.6 | 1.9 | 1.9 | 5.3 | 5.3 | 7.6 | 8.4 |
| Generously allowed | 0.3 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 |
| Disallowed | 0.0 | 0.0 | 0.5 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.8 |
| Weight matrix | 0.13 | 0.0044 | 5.44 | 0.055 | 8.00 | 0.15 | 2.50 | 0.080 | 0.31 | 0.0073 |
| Weight on pep1/pep2 | 2.5 | 0.5 | 0.2 | 2.0 | 0.6 | |||||
| Weight of RDCs | Yb, 0.3; Tm, 0.06; Tb, 0.06 | 0.1 | 0.1 | NH, CH, CH, 0.02; CCa, CN, 0.1 | Yb, 0.4; Tm, 0.08; Tb, 0.08 | |||||
| Weight of PCSs | 10 | 100 | ||||||||
Figure 1Calculated versus observed RDCs for cMMP1 refined with X-ray data only.
Figure 2Calculated versus observed PCSs (a) and RDCs (b) for cMMP1 refined with both X-ray and NMR (PCSs and RDCs) data.
Figure 3The crystal structure of MMP-1 (in yellow) and the refined structure with both X-ray and NMR data (in blue). Slight structural reorientations are visible, mainly of the bond vectors related to the observed RDCs.
Figure 4Calculated versus observed RDCs for Ub (a, b) and GB3 (c, d) before (a, c) and after (b, d) joint refinement against RDCs and X-ray data. The empty symbols in (b) show the values for residues 8 and 72.
Figure 5Calculated versus observed RDCs for CaM (a) and CaM–DAPk peptide (b) after joint refinement against NMR and X-ray data.